Human fibrinogen concentrate Fibryga® enables rapid reversal of thrombolysis and timely repair of acute Stanford type A aortic dissection: a case report
This case illustrates the diagnostic pitfall of ATAAD presenting as stroke and highlights the utility and safety of fibrinogen concentrate (Fibryga®) in rapid reversal of thrombolysis-associated coagulopathy, allowing for safe and timely surgical intervention for ATAAD.
Authors
- Charles A. Mack (ORCID: https://orcid.org/0000-0001-8142-9818)
- Iosif Gulkarov (ORCID: https://orcid.org/0000-0002-2687-7340)
- Berhane Worku (ORCID: https://orcid.org/0000-0002-6607-813X)
- Daniel Murdahayev
- Christopher Lau
Institutions
- Cornell University (US)
- CUNY School of Law (US)
- New York Hospital Queens (US)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1093/ehjcr/ytag046
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00